畜牧兽医学报
畜牧獸醫學報
축목수의학보
2001年
2期
170-174
,共5页
王志强%冯淇辉%陈杖榴%方炳虎
王誌彊%馮淇輝%陳杖榴%方炳虎
왕지강%풍기휘%진장류%방병호
环丙沙星%猪肺炎支原体%药效学%药物浓度监测
環丙沙星%豬肺炎支原體%藥效學%藥物濃度鑑測
배병사성%저폐염지원체%약효학%약물농도감측
测定环丙沙星及对照药物对猪肺炎支原体的最小抑菌浓度,其中环丙沙星的抗支原体活性最强,最小抑菌浓度为0.01 μg/ml。通过给18头健康猪气管内接种含有猪肺炎支原体的病肺悬液,复制具有典型症状的猪支原体性肺炎疾病模型,并进行环丙沙星2.5、5.0 mg/kg肌注给药对实验性猪支原体性肺炎的疗效实验及血浆药物浓度监测,两组治愈率分别为83.3%(5/6)和100%(6/6)。治疗组多剂量给药期间,第1、3、5、7、9次给药后0.5及6 h的血浆药物浓度,在2.5 mg/kg剂量组平均为0.41 μg/ml和0.17 μg/ml,5.0 mg/kg剂量组平均为0.71 μg/ml和0.28 μg/ml。两剂量组环丙沙星均无蓄积作用。
測定環丙沙星及對照藥物對豬肺炎支原體的最小抑菌濃度,其中環丙沙星的抗支原體活性最彊,最小抑菌濃度為0.01 μg/ml。通過給18頭健康豬氣管內接種含有豬肺炎支原體的病肺懸液,複製具有典型癥狀的豬支原體性肺炎疾病模型,併進行環丙沙星2.5、5.0 mg/kg肌註給藥對實驗性豬支原體性肺炎的療效實驗及血漿藥物濃度鑑測,兩組治愈率分彆為83.3%(5/6)和100%(6/6)。治療組多劑量給藥期間,第1、3、5、7、9次給藥後0.5及6 h的血漿藥物濃度,在2.5 mg/kg劑量組平均為0.41 μg/ml和0.17 μg/ml,5.0 mg/kg劑量組平均為0.71 μg/ml和0.28 μg/ml。兩劑量組環丙沙星均無蓄積作用。
측정배병사성급대조약물대저폐염지원체적최소억균농도,기중배병사성적항지원체활성최강,최소억균농도위0.01 μg/ml。통과급18두건강저기관내접충함유저폐염지원체적병폐현액,복제구유전형증상적저지원체성폐염질병모형,병진행배병사성2.5、5.0 mg/kg기주급약대실험성저지원체성폐염적료효실험급혈장약물농도감측,량조치유솔분별위83.3%(5/6)화100%(6/6)。치료조다제량급약기간,제1、3、5、7、9차급약후0.5급6 h적혈장약물농도,재2.5 mg/kg제량조평균위0.41 μg/ml화0.17 μg/ml,5.0 mg/kg제량조평균위0.71 μg/ml화0.28 μg/ml。량제량조배병사성균무축적작용。
The studies dealed with efficacy evaluation and monitored plasma drug concentration of ciprofloxaxin in pigs experimentally infected with Mycoplasma hyopneumoniae. In Vitro inhibitory tests showed that the MIC of ciprofloxacin against M.hyopneumoniae was 0.01 μg/ml. Pigs were experimentally induced mycoplasmal pneumonia and were treated by administration intramuscularly at the dose of 2.5 and 5.0 mg/kg of ciprofloxacin. The curative rates of two treated groups were 83.3% and 100%,respectively. The plasma concentrations were monitored 0.5 h and 6.0 h after the lst, 3rd, 5 th, 7th, 9th administration.The results showed that the mean plasma concentrations of ciprofloxacin 0.5 h and 6.0 h after administration were 0.41 μg/ml and 0.17 μg/ml in the low-dose group, 0.71 μg/ml and 0.28 μg/ml in the high-dose group,respectively.In addtion,after multiple doses,there was not significantly plasma accumulation of ciprofloxacin.